Abstract: A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.
Type:
Grant
Filed:
October 7, 2016
Date of Patent:
October 15, 2019
Assignee:
MicroBiome Therapeutics, LLC
Inventors:
Mark L. Heiman, Dean P. Stull, Justin W. Peno
Abstract: A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.
Type:
Grant
Filed:
August 17, 2012
Date of Patent:
October 11, 2016
Assignee:
MicroBiome Therapeutics, LLC
Inventors:
Mark L. Heiman, Dean P. Stull, Justin W. Peno
Abstract: Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure teaches compositions and methods for treating diabetes utilizing a gastrointestinal microbiome modulating composition.
Type:
Grant
Filed:
January 8, 2015
Date of Patent:
May 26, 2015
Assignee:
MicroBiome Therapeutics LLC.
Inventors:
Mark L. Heiman, Dean P. Stull, Justin W Peno
Abstract: Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure reaches compositions and methods for treating diabetes utilizing a gastrointestinal microbiome modulating composition.
Type:
Application
Filed:
January 8, 2015
Publication date:
April 30, 2015
Applicant:
MICROBIOME THERAPEUTICS LLC
Inventors:
Mark L. Heiman, Dean P. Stull, Justin W. Peno